RxDoctor Payments Data

Joannie Evans, APRN

Psychiatric/Mental Health · Gulfport, MSNPI 1386193183

Payments from drug & device makers

$3,947in general payments, 2019–2025

Across 227 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$634
  • Otsuka America Pharmaceutical, Inc.$386
  • Lundbeck LLC$325
  • Takeda Pharmaceuticals U.S.A., Inc.$201
  • Supernus Pharmaceuticals, Inc.$163
  • plus $739 from 13 others

What the payments were for

  • Food & beverage$3,87098%
  • Education$772%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,947 in reported general payments places this provider in the 85th percentile of 486 psychiatric/mental health providers in Mississippi.

See all psychiatric/mental health providers in Mississippi

Medicare billing

Part B allowed, 2024
$7,756
Medicare patients
21
Services billed
80

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine24$171,467
CaplytaLumateperone Tosylate21$49,737
TrintellixVortioxetine Hydrobromide13$5,998
Paliperidone ErPaliperidone12$1,735
Divalproex Sodium ErDivalproex Sodium17$1,096
Trifluoperazine Hcl11$1,002
Fluoxetine Hcl62$779
Bupropion XlBupropion Hcl23$692
Clonidine Hcl ErClonidine Hcl15$634
Duloxetine Hcl40$529
Gabapentin50$507
Trazodone Hcl75$504
Aripiprazole28$486
Olanzapine27$385
Quetiapine Fumarate79$385

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$152$171,46724 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$634$49,73721 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$201$5,99813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 486 psychiatric/mental health providers in Mississippi.

Other psychiatric/mental health in Gulfport

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →